Rasmus O. Bak

Dr. Rasmus O. Bak

Aarhus University, Aarhus, Midtjylland, Denmark
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2016 in Science
Verified
Journal Article
Open access
PDF file
DHDenes Hnisz
Denes Hnisz
AWAbraham S. Weintraub
Abraham S. Weintraub
DDDaniel S. Day
Daniel S. Day
AVAnne-Laure Valton
Anne-Laure Valton
Rasmus O. BakRasmus O. Bak
Rasmus O. Bak
RYRichard A. Young
Richard A. Young
The spread of bad neighborhoods: Our genomes have complex three-dimensional (3D) arrangements that partition and regulate gene expression. Cancer cells frequently have their genomes grossly rearranged, disturbing this intricate 3D organization. Hniszet al.show that the disruption of these 3D neighborhoods can bring oncogenes under the control of regulatory elements normally kept separate from them (see the Perspective by Wala and Beroukim). These novel juxtapositions can result in the inappropriate activation of oncogenes.Science, this issue p.1454; see also p.1398

1 September 2015 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
AHAyal Hendel
Ayal Hendel
Rasmus O. BakRasmus O. Bak
Rasmus O. Bak
JCJoseph T Clark
Joseph T Clark
AKAndrew B Kennedy
Andrew B Kennedy
DRDaniel E Ryan
Daniel E Ryan
MPMatthew H Porteus
Matthew H Porteus

7 November 2016 in Nature
Verified
Journal Article
Closed access
PDF file
DDDaniel P. Dever
Daniel P. Dever
Rasmus O. BakRasmus O. Bak
Rasmus O. Bak
ARAndreas Reinisch
Andreas Reinisch
JCJoab Camarena
Joab Camarena
GWGabriel Washington
Gabriel Washington
MPMatthew H. Porteus
Matthew H. Porteus

6 August 2018 in Nature Medicine
Verified
Journal Article
Open access
PDF file
CVChristopher A. Vakulskas
Christopher A. Vakulskas
DDDaniel P. Dever
Daniel P. Dever
GRGarrett R. Rettig
Garrett R. Rettig
RTRolf Turk
Rolf Turk
AJAshley M. Jacobi
Ashley M. Jacobi
MBMark A. Behlke
Mark A. Behlke
Translation of the CRISPR–Cas9 system to human therapeutics holds high promise. However, specificity remains a concern especially when modifying stem cell populations. We show that existing rationally engineered Cas9 high-fidelity variants have reduced on-target activity when using the therapeutically relevant ribonucleoprotein (RNP) delivery method. Therefore, we devised an unbiased bacterial screen to isolate variants that retain activity in the RNP format. Introduction of a single point mutation, p.R691A, in Cas9 (high-fidelity (HiFi) Cas9) retained the high on-target activity of Cas9 while reducing off-target editing. HiFi Cas9 induces robust AAV6-mediated gene targeting at five therapeutically relevant loci (HBB, IL2RG, CCR5, HEXB, and TRAC) in human CD34+ hematopoietic stem and progenitor cells (HSPCs) as well as primary T cells. We also show that HiFi Cas9 mediates high-level correction of the sickle cell disease (SCD)-causing p.E6V mutation in HSPCs derived from patients with SCD. We anticipate that HiFi Cas9 will have wide utility for both basic science and therapeutic genome-editing applications.

23 October 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MJMartin R. Jakobsen
Martin R. Jakobsen
Rasmus O. BakRasmus O. Bak
Rasmus O. Bak
AAAnnika Andersen
Annika Andersen
RBRandi K. Berg
Randi K. Berg
SJSøren B. Jensen
Søren B. Jensen
SPSøren R. Paludan
Søren R. Paludan
Significance: HIV-1 is a lentivirus and replicates through a replication cycle involving several DNA forms including ssDNA. Here we report that synthetic DNA oligos corresponding to DNA forms of the lentivirus replication cycle as well as viral DNA are detected by the immunological DNA sensor IFN-inducible protein 16 (IFI16) and stimulate innate immune responses through a pathway dependent on stimulator of IFN genes (STING). Moreover, we show that replication of HIV-1 is elevated in cells with decreased expression of IFI16 or STING. We suggest IFI16 is a sensor for lentivirus DNA in macrophages stimulating innate immune responses, which contribute to early control of the virus.

25 January 2018 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
Rasmus O. BakRasmus O. Bak
Rasmus O. Bak
DDDaniel P Dever
Daniel P Dever
MPMatthew H Porteus
Matthew H Porteus